GLAND PHARMA TO FLOAT AN IPO TO RAISE RS. 7,000 CR - IN INDIA
In any case, the Hyderabad-based pharmaceutical organization Gland Pharma documented its draft distraction plan with SEBI. Prominently, the Initial public offering comprises of a new issue of up to Rs. 1,250 crores. Additionally, its proposal available to be purchased comes up to 3,48,63,635 value shares by advertisers. https://stockinvestorfinance.blogspot.com/2020/07/gland-pharma-to-float-ipo-to-raise-rs.html
4.00/5
1 reviews
Price:
₹ 0,00
₹ 0,00
Contact
CONTACT